Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis

Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis

Abstract Background Systemic therapy is the standard treatment for unresectable colorectal cancer with liver metastasis (CRCLM). Transarterial chemoembolization with drug-eluting beads (DEB-TACE) is considered an effective treatment option for CRCLM. Few studies have investigated the combination of...

Full description

Bibliographic Details
Main Authors:	Yen-Cheng Chen, Ching-Wen Huang, Ching-Chun Li, Tsung-Kun Chang, Wei-Chih Su, Po-Jung Chen, Yung-Sung Yeh, Yu-Tang Chang, Hsiang-Lin Tsai, Ming-Chen Paul Shih, Jaw-Yuan Wang
Format:	Article
Language:	English
Published:	BMC 2023-12-01
Series:	World Journal of Surgical Oncology
Subjects:	Colorectal cancer with liver metastasis Drug-eluting bead Trans-arterial chemoembolization Targeted therapy Chemotherapy
Online Access:	https://doi.org/10.1186/s12957-023-03253-w

Similar Items

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma
by: Murtuza Razi, et al.
Published: (2021-02-01)

Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma
by: Mohammad Arabi, et al.
Published: (2015-01-01)

Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Khalid I. Bzeizi, et al.
Published: (2021-12-01)

Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma
by: Yonghua Bi, et al.
Published: (2021-05-01)

The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer
by: Yonghua Bi, et al.
Published: (2022-11-01)

Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
by: Ji K, et al.
Published: (2022-06-01)

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
by: Hao Li, et al.
Published: (2023-12-01)

Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Kazue Shiozawa, et al.
Published: (2014-11-01)

Super-Selective Transarterial Chemoembolization with Doxorubicin-Loaded Drug-Eluting Beads Sized Below and Above 100 Microns in Hepatocellular Carcinoma: A Comparative Study
by: Huseyin Balli, et al.
Published: (2019-07-01)

CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study
by: Baolin Wu, et al.
Published: (2018-03-01)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01)

Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study
by: Shi Q, et al.
Published: (2020-07-01)

Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads in Hepatocellular Carcinoma: A Single-Center Experience
by: Erbil Arık, et al.
Published: (2022-08-01)

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
by: Cao G, et al.
Published: (2021-07-01)

Comparison of Clinical Efficacy and Safety between 70–150 µm and 100–300 µm Doxorubicin Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Jung Woo Yi, et al.
Published: (2022-02-01)

Retrospective analysis of efficacy, safety, and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization
by: Sihan Chen, et al.
Published: (2019-11-01)

Development of a Prognostic Nomogram in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Following Trans-Arterial Chemoembolization with Drug-Eluting Beads
by: Cheng S, et al.
Published: (2021-12-01)

Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer
by: Wenhui Wang, et al.
Published: (2022-09-01)

Transarterial chemoembolization as a part of multi-modality treatment with drug-eluting beads for locally advanced breast cancer: A case report
by: Jau-Nan Lin, et al.
Published: (2021-11-01)

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302
by: Masafumi Ikeda, et al.
Published: (2022-06-01)

Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound
by: Kazue Shiozawa, et al.
Published: (2021-02-01)

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
by: Huang J, et al.
Published: (2021-11-01)

Effects of HepaSphere microsphere encapsule epirubicin with a new loading method transarterial chemoembolization: in vitro and in vivo experiments
by: Wen Zhang, et al.
Published: (2023-11-01)

The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients
by: Ma X, et al.
Published: (2024-03-01)

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
by: Yi-Sheng Liu, et al.
Published: (2018-08-01)

Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2021-10-01)

Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
by: Wu SJ, et al.
Published: (2023-06-01)

Trans-Arterial Chemoembolization with 50 μm Degradable Starch Microspheres Versus 300–500 μm Drug Eluting Beads in Hepatocellular Carcinoma: A Comparative Analysis of Initial Treatment Outcomes
by: Isil Yildiz, et al.
Published: (2022-03-01)

Diagnostic accuracy of intermediate b-value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads
by: Ahmed E Hassan, et al.
Published: (2019-04-01)

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
by: Waleed M. Hetta, et al.
Published: (2014-09-01)

Irinotecan drug eluting beads used as a treatment of advanced intra hepatic cholangiocarcinoma
by: Jean Amede Roch, et al.
Published: (2008-10-01)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen W, et al.
Published: (2017-10-01)

Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients
by: Ning Peng, et al.
Published: (2022-08-01)

Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Shiro Miyayama
Published: (2020-10-01)

Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control
by: Popovic Peter, et al.
Published: (2016-12-01)

Clinical outcomes of gemcitabine-loaded callispheres drug-eluting beads for patients with advanced and inoperable lung cancer: A case series study
by: Yonghua Bi, et al.
Published: (2022-09-01)

Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
by: Donglin Kuang, et al.
Published: (2023-04-01)